目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Gene Panel Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Gene Panel Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Gene Panel Market: Products & Services Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Gene Panel Market: Products & Services Movement Analysis, 2023 & 2030 (USD Million)
4.3. Test Kits
4.3.1. Test Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Testing Services
4.4.1. Testing Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Gene Panel Market: Technique Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Gene Panel Market: Technique Movement Analysis, 2023 & 2030 (USD Million)
5.3. Amplicon Based Approach
5.3.1. Amplicon Based Approach Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Hybridization Based Approach
5.4.1. Hybridization Based Approach Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Gene Panel Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Gene Panel Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Academic & Research Institutes
6.3.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Hospital & Diagnostic Laboratories
6.4.1. Hospital & Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Pharmaceutical & Biotechnology Companies
6.5.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Gene Panel Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Gene Panel Market: Application Movement Analysis, 2023 & 2030 (USD Million)
7.3. Cancer Risk Assessment
7.3.1. Cancer Risk Assessment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Diagnosis of Congenital Diseases
7.4.1. Diagnosis of Congenital Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Pharmacogenetics
7.5.1. Pharmacogenetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Other Applications.
7.6.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Gene Panel Market: Regional Estimates & Trend Analysis
8.1. Gene Panel Market Share, By Region, 2023 & 2030 (USD Million)
8.2. North America
8.2.1. North America Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. UK Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. France Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacifics
8.4.1. Asia Pacific Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. China
8.4.2.1. China Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. Japan
8.4.3.1. Japan Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. India Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. South Korea
8.4.5.1. South Korea Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. Australia
8.4.6.1. Australia Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. Saudi Arabia
8.6.2.1. Saudi Arabia Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. UAE
8.6.3.1. UAE Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. South Africa
8.6.4.1. South Africa Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Agilent Technologies
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Illumina Inc.
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. Qiagen Inc.
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. Eurofins Genomics
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Thermo Fisher Scientific, Inc.
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Foundation Medicine, Inc.
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Guardant Health, Inc.
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Cepheid
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. Bio-Rad Laboratories, Inc.
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. Personalis
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives